Comparison of Abdominal Aortic Aneurysm growth in adult smoking patients who either switch to Platform 1, continue smoking, or quit smoking
A controlled, open-label, 3-arm parallel group, multi-center study to evaluate the Abdominal Aortic Aneurysm (AAA) growth rate in adult smoking patients randomized to either cigarette smoking or Platform 1 use and to compare with the AAA growth rate in patients who had stopped smoking
The purpose of this study is to evaluate the reduction of the Abdominal Aortic Aneurysm (AAA) annual growth rate in patients who switch from smoking cigarettes to using Platform 1 as compared to patients who continue to smoke cigarettes. The study also aims to provide context to the scale of reduction in the growth rate, by comparing the AAA annual growth rates for continuing to smoke and switching to Platform 1 with the AAA annual growth rate in smokers who had stopped smoking. The study will further evaluate the effects of switching to Platform 1 on co-morbidities observed in AAA patients that are related to smoking as well as to assess the effects on relevant clinical risk endpoints linked to smoking related diseases.
|Study Results||No Results Available|
Published OnFebruary 12, 2019